Vanguard Group Inc Ionis Pharmaceuticals Inc Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 15,055,758 shares of IONS stock, worth $543 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,055,758
Previous 13,845,712 8.74%
Holding current value
$543 Million
Previous $660 Million 8.6%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$40.06 - $51.86 $48.5 Million - $62.8 Million
1,210,046 Added 8.74%
15,055,758 $603 Million
Q2 2024

Aug 13, 2024
BUY
$36.45 - $47.7 $15.1 Million - $19.8 Million
415,256 Added 3.09%
13,845,712 $660 Million
Q1 2024

May 10, 2024
SELL
$42.03 - $53.55 $32.5 Million - $41.4 Million
-773,025 Reduced 5.44%
13,430,456 $582 Million
Q4 2023

Feb 14, 2024
SELL
$43.39 - $51.63 $13 Million - $15.4 Million
-298,544 Reduced 2.06%
14,203,481 $719 Million
Q3 2023

Nov 14, 2023
SELL
$38.5 - $47.13 $817,778 - $1 Million
-21,241 Reduced 0.15%
14,502,025 $658 Million
Q2 2023

Aug 14, 2023
BUY
$34.73 - $43.33 $19 Million - $23.7 Million
547,476 Added 3.92%
14,523,266 $596 Million
Q1 2023

May 15, 2023
BUY
$33.58 - $41.2 $14.4 Million - $17.7 Million
429,096 Added 3.17%
13,975,790 $499 Million
Q4 2022

Feb 10, 2023
BUY
$37.12 - $46.52 $27.5 Million - $34.5 Million
740,671 Added 5.78%
13,546,694 $512 Million
Q3 2022

Nov 14, 2022
BUY
$36.54 - $48.66 $22.1 Million - $29.5 Million
605,747 Added 4.97%
12,806,023 $566 Million
Q2 2022

Aug 12, 2022
BUY
$31.71 - $43.0 $3.21 Million - $4.35 Million
101,242 Added 0.84%
12,200,276 $452 Million
Q1 2022

May 13, 2022
BUY
$29.88 - $37.04 $2.75 Million - $3.41 Million
91,958 Added 0.77%
12,099,034 $448 Million
Q4 2021

Feb 14, 2022
BUY
$25.61 - $35.1 $5.3 Million - $7.27 Million
207,067 Added 1.75%
12,007,076 $365 Million
Q3 2021

Nov 12, 2021
SELL
$33.54 - $40.55 $28.7 Million - $34.7 Million
-855,820 Reduced 6.76%
11,800,009 $396 Million
Q2 2021

Aug 13, 2021
BUY
$34.54 - $47.25 $437 Million - $598 Million
12,655,829 New
12,655,829 $505 Million

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.12B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email